Related Articles
Targeted chemotherapy for triple-negative breast cancers via LHRH receptor
Receptor mediated antiproliferative effects of the cytotoxic LHRH agonist AN-152 in human ovarian and endometrial cancer cell lines.
Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness
Luteinizing hormone-releasing hormone as an autocrine growth factor in ES-2 ovarian cancer cell line.
LH-RH receptors in human colorectal cancers: Unexpected molecular targets for experimental therapy